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Abstract
Purpose: to demonstrate the effect of matrix microparticles of Co-
paifera langsdorffii (aerial parts of copaiba), aiming to evaluate the 
discussions and results of the works that demonstrate Its function on 
the kidneys as well as its effectiveness.
Methods: A bibliographic study was carried out by consulting public 
online databases of patents, such as the United States Patent and 
Trademark office, World Intellectual Property Organization and the 
National Intellectual Property Institute; The following keywords were 
used: copaiba oil, renal function, kidney, kidney stones, matrix micro-
particles Copaifera langsdorffii and lithiasis. In this study were included 
patents of invention, innovations and utility models in the period from 
January 2007 to May 2016.
Results: One patent register was included regarding a method for 
obtaining microparticles and compounds, having antilithiasic, analge-
sic, antispasmodic, anti-inflammatory, diuretic and antiseptic activity.
Conclusion: The patent registry survey demonstrates the possibility 
of beneficial action of matrix microparticles Copaifera langsdorffii on 
renal physiology, acting as antilithiasis and even with diuretic proper-
ties, thus opening up new possibilities of research of this substance 
on renal physiology.
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Introduction
The world market for herbal medicines represents 
a significant part of the medicine sector, moving 
globally 21.7 billion dollars a year [1]. The main 
movement in the world is concentrated in Euro-
pe, with 50% in Germany. Next, Asia and Japan 
appear. However, no other market grows as much 
as the North American market [1]. In Brazil, there 
is no up-to-date official data, but it is estimated 
that this market is around 160 million dollars per 
year [2].
The largest plant biodiversity in the world, esti-
mated at about 200,000 plant species, is located 
in Brazil. However, the data show that only 15 to 
17% of the species were studied for their medicinal 
potential, justifying the search for further develop-
ment in this area the basis of our research is the 
use of copaiba and its by-products [3]. The oil-resin 
extracted from the copaibeira receives indication of 
traditional medicine, for innumerable purposes, of 
the most different natures, and has been for seve-
ral years the subject of several studies, aiming at 
proving them or adapting them to new therapies 
[4]. In 1972, the US Food and Drug Administration 
approved copaiba oil, after undergoing sensitization 
and irritation tests, with the use of twenty-five vo-
lunteers [5]. 
In the present study, a systematic review was 
carried out in the literature based on the search 
of patent data to demonstrate the effect of matrix 
microparticles of Copaifera langsdorffii (aerial parts 
of copaiba), aiming to evaluate the discussions and 
results of the works that demonstrate Its function 
on the kidneys as well as its effectiveness.
Methods
The research is characterized as a quantitative-
qualitative, retrospective and cross-sectional bi-
bliographic study based on electronic consultation 
(on-line) in main public databases of patents with 
registration on the internet in the period deter-
mined from January 2007 to May 2016; (www.
patentesonline.com.br) and in patent database of 
the National Intellectual Property Institute (www.
inpi.gov.br). The following descriptors were used 
in the records search: patentes, óleo de copaíba, 
função renal, litíase, micropartículas matriciais de 
Copaifera langsdorffii (partes aéreas), cálculo renal 
and litíase.
In the international patent search, advanced 
searches were used in the database of the United 
States Patent and Trademark Office (patft.uspto.
gov), Google patents (patents.google.com), World 
Intellectual Property Organization (www.wipo.int), 
Espacenet (www.ep.espacenet.com) and Free pa-
tents on line (www.freepatentsonline.com). The 
following keywords were found in the search: 
copaiba oil, renal function, kidney, kidney stones, 
matrix microparticles Copaifera langsdorffii and 
lithiasis. 
In the study were included records of inventions, 
innovations and utility models regarding the use of 
technologies for the purpose of performing oil or 
other by-products of copaiba and its action on renal 
function, excluding records prior to 2007, a patent, 
and related inventions the use of compounds com-
bined with other substances and the use for other 
purposes, such as cosmetics, for example, a further 
78 patents being excluded.
Results
In the search for patents concerning the use of 
copaiba oil and its probable action on renal phy-
siology, no patent was found, using the key words 
copaiba oil and kidney, only with the use of ae-
rial parts the invention relates to a method for 
obtaining microparticles of Copaifera langsdorffii 
(aerial parts) and isolating the active principles; Mi-
croparticles and compounds thus obtained, having 
antilithiasic, analgesic, antispasmodic, anti-inflam-
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matory, diuretic and antiseptic activity, their for-
mulations, products and uses" under registration 
WO2011120118A1 [6].
Discussion
In the research of database of patent registry was 
found an important action of Copaifera in preven-
tion of renal calculations, an action that is unprece-
dented in the renal physiology, having in literature 
only the description of this unique patent. In the 
case of renal lithiasis, more than 70 species with 
antilithiasic properties are described. It stands out 
the plant species Phyllanthus niruri, popularly de-
nominated by stone breaker, for treatment of uro-
lithiasis [7-9].
This is a paradox because, despite the large amou-
nt of species, there are few well-described scienti-
fic studies aiming to evaluate these properties. An 
example of this is the lack in Brazil of patents on 
active principles and/or drugs capable of effectively 
exercising such action.
Among the medicinal plants and traditional use, 
Copaifera sp., a native Brazilian plant very popu-
larly used by the Indians of the sixteenth century. 
In Brazil, there are over twenty species of the genus 
Copaifera used with the same therapeutic actions. 
Some species are very popular name in both Portu-
guese and possibly in other languages. In particular, 
C. langsdorffi is denominated red copaiba, red oil 
or copaiba meadow in Amazonas, copaibeira of Mi-
nes, cupiúva or podoi in Piauí and Ceará, potter or 
cabimo in Venezuela [10].
 The literature provides several studies of biologi-
cal activities of oil-resin of several genus of Copai-
fera sp. [5, 10-15] as its healing action, antiseptic 
and anti-inflammatory of respiratory airways [10], 
analgesic, antibacterial, antitumor, antioxidant, 
healing, gastroprotective, anthelmintic, leishmani-
cide, tripanomicide, muscle relaxant among many 
others [5, 10, 11]. In its specific action on renal 
physiology there was the description of diuretic 
properties [5].
However, studies on Copaifera sp leaves are 
scarce in the literature except for the study of their 
constituents in ecological interactions [16-18]. In the 
chemical composition of Copaifera langsdorffi lea-
ves, 3% of amino acid N-methyl-trans-4-hydroxy-
L-proline and sesquiterpenes, such as α-cubebene, 
σ-copaene, cyperene, 3-copaene, caryophyllene, 
β-humulene, muurolene, 3-selinene, δ-cadinene 
and γ-cadinene [16-18].
In contrast, in the oil-resin of the species of C. 
langsdorffi presents as main chemical constituents 
tetracyclic diterpenes of kaurano series, as kaure-
noic and kauranoic acids [19], clerodanes such as 
hardwic acid [20] and labdanum diterpenes such as 
copalic acid [21, 22], sesquiterpenes, predominating 
ß-caryophyllene, 3-bisabolene, σ-bergamotene and 
ß-selinen [4, 23]. 
The process of obtaining matrix microparticles 
containing Copaifera langsdorffii extracts has a 
very advantageous technological system in relation 
to the use of lyophilized extracts, which provides 
greater protection and stability to the compounds 
identified in the extract, homogeneity of the sys-
tem, modified release, reduced size of particle and 
morphology that provide better pharmacotechnical 
development, endowed with excellent biological 
activity. 
The lyophilized extracts may undergo degrada-
tion processes, decomposition of the compounds of 
interest, and offer larger particles with large granu-
lometric variation, which are deformed and difficult 
to handle pharmaceutically. Also, it is noted that 
chemical composition of aerial parts of Copaifera 
sp. is completely different from that observed on 
copaiba oil, which is obtained from stem of the 
plant [5]. 
In the scientific literature there are reports only of 
the antilithiasic activity, with the use of hydroalco-
holic extract of copaiba in experimental studies [24], 
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however does not contemplate any data referring to 
the study of the leaves of Copaifera langsdorffii, and 
that the standardized extract and its isolated subs-
tances obtained from the aerial parts, are shown 
to exhibit antilithiasic, anti-inflammatory, analgesic, 
antispasmodic, antiseptic and diuretic properties, as 
described in said patent.
Conclusion
The patent registry survey demonstrates the pos-
sibility of beneficial action of matrix microparticles 
Copaifera langsdorffii (aerial parts) on renal phy-
siology, acting as antilithiasis and even with diu-
retic properties, thus opening up a possibility of 
opening new lines of action research of this subs-
tance on renal physiology, the shortage of patents 
that register and explore the study on this plant 
is highlighted.
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